Cancer therapy evaluation program (http://ctep.info.nih.gov/)

被引：0
|
作者：
Fukuda, H
机构：
来源：
JAPANESE JOURNAL OF CLINICAL ONCOLOGY | 2000年 / 30卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [1] National Toxicology Program's updated website http://ntp.niehs.nih.gov
    Eastin, WC
    TOXICOLOGIC PATHOLOGY, 2005, 33 (07) : 800 - 801
  • [2] The Cancer Therapy Evaluation Program (CTEP) at the National Cancer Institute - Industry collaborations in new agent development
    Ansher, SS
    Scharf, R
    SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 333 - 340
  • [3] Pediatric drug development: A perspective from the cancer therapy evaluation program (CTEP) of the National Cancer Institute (NCI)
    Smith, M
    Ho, PTC
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (01) : 11 - 22
  • [4] Analysis of Lung Cancer Patients Enrolled in CTEP (Cancer Therapy Evaluation Program)-Sponsored Phase I Trials
    Gadgeel, Shirish M.
    Ivy, Percy
    Chen, Wei
    Mauer, Joan
    Smith, Daryn
    LoRusso, Patricia
    CLINICAL LUNG CANCER, 2011, 12 (04) : 218 - 223
  • [5] Pregnancies in subjects on oncology clinical trials: Analysis from the Cancer Therapy Evaluation Program (CTEP) database.
    Mittra, Arjun
    Murray, James
    Takebe, Naoko
    Chen, Alice P.
    Ivy, S. Percy
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] The Cancer Therapy Evaluation Program's (CTEP) implementation of the Operational Efficiency Working Group (OEWG) recommendations.
    DiPiazza, K.
    Souhan, E.
    Finnigan, S.
    Denicoff, A.
    Friedman, S.
    Montello, M.
    Mooney, M. M.
    Schettino, P.
    Zwiebel, J. A.
    Doroshow, J. H.
    Abrams, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Characteristics and outcome of breast cancer patients enrolled in cancer therapy evaluation program (CTEP) sponsored phase I clinical trials
    Lynce, Filipa
    Rubinstein, Larry
    Harris, Pamela
    CANCER RESEARCH, 2015, 75
  • [8] Unbiased Drug Discovery Approaches to Identify Novel Radiosensitizers from Cancer Therapy Evaluation Program (CTEP) Portfolio of Drugs in Pancreatic Cancer
    Singh, P. K.
    Venkatesulu, B. P.
    Symons, J.
    Mahadevan, L. S. K.
    Sanders, K. L.
    Kim, B. K.
    Krishnan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S163 - S163
  • [9] Analysis of esophagogastric cancer patients enrolled in National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP)-sponsored phase I trials
    Bando, Hideaki
    Rubinstein, Larry
    Harris, Pamela Jo
    Yoshino, Takayuki
    Doi, Toshihiko
    Ohtsu, Atsushi
    Welch, Jack
    Takebe, Naoko
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [10] Phase I Studies in Hematologic Malignancy: 20-Year Experience from Cancer Therapy Evaluation Program (CTEP) at National Cancer Institute/National Institutes of Health
    Chihara, Dai
    Huang, Erich P.
    Finnigan, Shanda R.
    Cordes, Lisa M.
    Skorupan, Nebojsa
    Fukuda, Yoko Korenaga
    Rubinstein, Larry V.
    Takebe, Naoko
    BLOOD, 2020, 136
12345